2. Identify weaknesses in the health care system and its improvement by using clinical criteria. METHODS: The Czech health care system uses comprehensive national "administrative" databases such as insurance billing data or national health care statistics, but also many extensive "clinic-specific" databases such as national cancer database and other clinical registers for cardiology, hip replacements, etc. We use some of these data for designing and testing quality and performance indicators in coordination with clinical guidelines development. We plan to use some of these "clinic-specific" databases in the near future for the same purposes. RESULTS: It has been two years since we started assessing significant benefits, especially in cancer prevention, and introducing arrangements enhancing care in some specialties while simultaneously developing guidelines and indicators. The poster presents the general framework of our methodology and some of the examples of joined guidelines and indicators, focusing on weaknesses in the health care system and its improvement. 
LEARNING OBJECTIVES (TRAINING GOALS):
1. Present a new methodology to grade agreement in formal consensus with ordinal scales or a reduced number of participating experts. 2. Present our experience with the use of this new methodology. METHODS: Considering the ordinal nature of the scales proposed to grade agreement in formal consensus groups, and that in our country the availability of experts to take part in such groups is limited, we propose a methodology that integrates these characteristics (ordinal nature of grading scales and limited size groups). We have developed a system based in non-parametric methods (Kruskal Wallis test with post hoc comparisons) using the following decision parameters for the absence of consensus: no statistical difference in the punctuation assigned to items of a question with only two answer choices; no statistical difference in the punctuation assigned to more than two of the choices with the highest vote count in a question with more than two choices. If there are options with medians under six (considering the confidence intervals), these are not included in the consensus declaration. RESULTS: This methodology has been used in five consensuses on oncology topics. The number of participants has varied between 12 and 84 experts. This method has proved efficient to grade expert agreement within the context of generation of recommendations for clinical practice guidelines.
DISCUSSION (CONCLUSION):
This methodology is useful to grade agreement in formal consensus with ordinal scales or a reduced number of participating experts. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Guideline implementer 5. Developer of guideline-based products 6. Quality improvement manager/facilitator 7. Medical educator 8. Health care policy analyst/policy-maker 9. Health insurance payers and purchasers 10. Medical providers and executives 11. Allied health professionals 12. Consumers and patients representatives 13. Nurses
P27-Guideline development group processes:
How should guideline development groups function? Elizabeth J. Shaw, MS (NICE, Manchester, England, United Kingdom); Kathryn Chamberlain (Presenter) (NICE, Manchester, England, United Kingdom); Lynda Ayiku (NICE, Manchester, England, United Kingdom) PRIMARY TRACK: Guideline development SECONDARY TRACK: Guideline development groups/ panels/committees BACKGROUND (INTRODUCTION): Guideline developers are embedded in an evidence-based world -however, how many of the processes used to develop clinical practice guidelines are themselves evidence based? There is a lot of methodological and empirical evidence on the methods of guideline development, such as systematic reviewing and evidence synthesis, but there appears to be a significant gap in the process of guideline development specifically related to group functioning and decision-making. LEARNING OBJECTIVES (TRAINING GOALS): 1. To review published evidence on group processes associated with the development of clinical practice guidelines (including recruitment and selection of members, training and support, chairing and facilitation, and organization). 2. To evaluate studies of interventions to improve the functioning of guideline development groups. METHODS: [This review is ongoing, so the methods and results are based on preliminary work only.] We undertook a focused review on relevant published literature. We did not consider a comprehensive, systematic review appropriate due to the expected heterogeneity of literature, but we did aim to identify key articles specifically related to group processes in the development of evidence-based guidelines and any associated interventions. RESULTS: Preliminary results suggest that although there is some empirical evidence describing group processes, there is very little comparing different approaches to, or theoretical models of, group functioning related to guideline development. Where possible, we will illustrate identified barriers and facilitators through examples from a national guideline program. DISCUSSION (CONCLUSION): Group decision-making is well researched in the wider arena of the organizational, management, and social sciences. However, we do not yet know which models or theories apply to guideline development groups, and more importantly, which interventions or approaches can be used to improve their functioning. TARGET AUDIENCE(S): 1. Guideline developer 2. Medical educator
